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 ABSTRACT 
 The objective of this study was to evaluate local 
molecular adaptations proposed to regulate protein 
synthesis in the mammary glands. It was hypothesized 
that AA and energy-yielding substrates independently 
regulate AA metabolism and protein synthesis in mam-
mary glands by a combination of systemic and local 
mechanisms. Six primiparous mid-lactation Holstein 
cows with ruminal cannulas were randomly assigned 
to 4 treatment sequences in a replicated incomplete 4 
× 4 Latin square design experiment. Treatments were 
abomasal infusions of casein and starch in a 2 × 2 fac-
torial arrangement. All animals received the same basal 
diet (17.6% crude protein and 6.61 MJ of net energy for 
lactation/kg of DM) throughout the study. Cows were 
restricted to 70% of ad libitum intake and abomasally 
infused for 36 h with water, casein (0.86 kg/d), starch 
(2 kg/d), or a combination (2 kg/d starch + 0.86 kg/d 
casein) using peristaltic pumps. Milk yields and com-
position were assessed throughout the study. Arterial 
and venous plasma samples were collected every 20 
min during the last 8 h of infusion to assess mammary 
uptake. Mammary biopsy samples were collected at the 
end of each infusion and assessed for the phosphoryla-
tion state of selected intracellular signaling molecules 
that regulate protein synthesis. Animals infused with 
casein had increased arterial concentrations of AA, 
increased mammary extraction of AA from plasma, 
either no change or a trend for reduced mammary AA 
clearance rates, and no change in milk protein yield. 
Animals infused with starch had increased milk and 
milk protein yields, increased mammary plasma flow, 
reduced arterial concentrations of AA, and increased 
mammary clearance rates and net uptake of some AA. 
Infusions of starch increased plasma concentrations of 
glucose, insulin, and insulin-like growth factor-I. Starch 
infusions increased phosphorylation of ribosomal pro-
tein S6 and endothelial nitric oxide synthase, consistent 
with changes in milk protein yields and plasma flow, 
respectively. Phosphorylation of the mammalian target 
of rapamycin was increased in response to starch only 
when casein was also infused. Thus, cell signaling mol-
ecules involved in the regulation of protein synthesis 
differentially responded to these nutritional stimuli. 
The hypothesized independent effects of casein and 
starch on animal metabolism and cell signaling were 
not observed, presumably because of the lack of a milk 
protein response to infused casein. 
 Key words:   amino acid ,  cell signaling ,  mammary 
gland 
 INTRODUCTION 
 Stimulation of milk protein synthesis at a given sup-
ply of AA is a potential strategy to reduce AA ca-
tabolism. If AA supply remains constant while use for 
milk protein synthesis is increased, reductions in arte-
rial concentrations of AA should lead to reduced AA 
catabolism by the splanchnic tissues (Hanigan et al., 
1998a). Conversely, increased AA removal by the mam-
mary glands (MG) in the absence of greater protein 
synthesis would likely increase AA degradation within 
the tissue (Bequette et al., 1996a,b). Experiments to 
increase intracellular concentrations of AA resulted in 
increased oxidation of AA (Bequette et al., 1996a; Rag-
gio et al., 2006). Reduced concentrations of circulating 
AA triggered a greater proportional mammary capture, 
although there was some loss of production (Bequette 
et al., 2000; Raggio et al., 2006). The increased AA 
capture occurs through stimulation of mammary AA 
clearance rate. For example, limiting arterial concen-
trations of His from 73 to 8 μM elicited a 43-fold in-
crease in its clearance rate by the MG (Bequette et al., 
2000). This is likely an adaptive mechanism used to 
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maintain milk protein output in the face of shortages in 
one or more AA. Similar adaptations in hepatic tissue 
have not been reported (Hanigan et al., 1998b, 2004). 
Therefore, limiting the supply of AA to the animal by 
low-protein diets should shift AA partitioning toward 
milk production and increase overall N efficiency. The 
challenge is to achieve this while avoiding reductions in 
milk protein output.
In general, increasing the intake of nonstructural 
carbohydrate, particularly corn starch, increases milk 
and milk protein yield and N efficiency in lactating 
cows (Broderick, 2003; Rius et al., 2010). Increasing 
energy supply to the MG was suggested as a plausible 
nutritional intervention to stimulate mammary protein 
synthesis and milk protein production (Hanigan et al., 
1998a). For example, increased duodenal glucose supply 
in cows fed isonitrogenous diets caused hyperglycemia 
and stimulated insulin secretion and milk protein yield 
(Rulquin et al., 2004). Similar results were observed 
when insulin and glucose were infused systemically 
(Mackle et al., 2000), suggesting that the effect is en-
tirely postabsorptive. Therefore, energy supply either 
directly or via insulin should interact with AA supply 
in determining milk protein synthesis and overall N ef-
ficiency.
Insulin and AA have been reported to regulate initia-
tion of protein synthesis independently in muscle tissue 
of growing animals (Davis et al., 1991, 2001) by activa-
tion of the mammalian target of rapamycin (mTOR) 
signaling cascade (Escobar et al., 2006). Activity of 
mTOR signaling proteins in mammary cells increased 
with greater AA availability, and this response was 
enhanced by lactogenic hormones (Burgos et al., 2010). 
Increased mTOR activity corresponds with greater AA 
utilization for protein synthesis in growing animals; 
however, this molecular mechanism is not fully under-
stood in the MG of lactating cows.
Greater milk and milk protein production in lactat-
ing cows fed high-starch diets compared with those fed 
low-starch diets has been reported (Rius et al., 2010). 
This response in production was observed even though 
dietary protein was lower than recommended (15.2% 
CP, DM basis). However, mammary metabolism and 
molecular mechanisms were not evaluated. The objec-
tives of the work reported herein were to determine 
the effects of starch and protein intake on MG blood 
flow, AA capture, intracellular signaling, and protein 
synthesis. It was hypothesized that AA and glucogenic 
substrate could alter intracellular signaling and protein 
synthesis independently.
MATERIALS AND METHODS
Animals and Housing
All experimental procedures were approved by the In-
stitutional Animal Care and Use Committee of Virginia 
Tech. Six primiparous Holstein cows averaging 612 kg 
of BW and 160 DIM were fitted with a ruminal can-
nula 55 d before commencement of the study. Animals 
were housed in a freestall barn with constant access to 
water and feed. A common TMR (Table 1) was mixed 
at 0800 h and offered daily during 14-d periods. Feed 
was offered ad libitum the first 12 d and restricted to 
70% of ad libitum intake on an individual basis for the 
last 48 h of each period. Diets were formulated to meet 
all NRC (2001) recommendations for a mid-lactation 
cow weighing 650 kg, consuming 22 kg of TMR, and 
producing 40 kg/d of milk with 3.0% CP and 3.5% fat. 
Final diets contained 45% forage and 55% concentrate 
on a DM basis. The DM content of the forages was 
monitored weekly and used to adjust the mix to main-
tain constant DM proportions in the final diet. Samples 
of forages and concentrates were taken daily during 
the last week of each period, pooled, and submitted to 
Dairyland Laboratories (Arcadia, WI) for analyses of 
nutrients.
Treatments
The effect of 2 levels of abomasal starch and casein 
infusions were tested in a 2 × 2 factorial arrangement 
using a replicated Latin square design with 2 squares 
and 4 periods. One square was complete and 4 cows 
were used. The second square was incomplete and 2 
cows were used. Cows were randomly assigned to treat-
ment sequence within square. The study consisted of 
four 14-d periods. The first 10 d of each period were al-
lotted for diet acclimation of the animals and washout 
of the previous treatment. On d 11, cows were moved 
to a metabolism unit with individual tie stalls, and 
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Table 1. Ingredient composition of the basal diet during the 
experiment offered to lactating dairy cows infused with starch and 
casein in the abomasum 
Item % of DM
Corn silage 40.00
Mix grass + legume silage 5.00
Soybean hulls 21.66
Corn grain, ground, dry 14.50
Soybean meal, solvent (48% CP) 12.40
Protected soybean meal 4.78
Calcium carbonate 0.30
Calcium phosphate (di-) 0.20
Sodium bicarbonate 0.20
Sodium selenate 0.04
Salt 0.40
Vitamins and trace minerals1 0.01
1Vitamin A, D, E, magnesium oxide, manganous oxide, zinc oxide, hy-
drated sulfate, cobalt carbonate, ferrous sulfate, and copper sulfate.
abomasal infusion lines were placed manually via the 
ruminal cannula and checked daily to ensure proper 
placement. There were no problems with lines becom-
ing dislodged after the initial placement. When cows 
were in the metabolism unit, rectal temperatures were 
taken twice daily and cows were observed for signs of 
illness. Milk samples were checked at each milking for 
signs of mastitis. On d 13 and 14, the TMR offered 
was restricted to 70% of the observed ad libitum intake 
over the previous 10 d for each animal. During the time 
that intake was restricted, the TMR was subdivided 
into 8 equal proportions delivered at 0300, 0600, 0900, 
1200, 1500, 1800, 2100, and 2400 h on d 13 and 0300, 
0600, 0900, 1200, and 1500 h on d 14. At 0400 h on d 
13, abomasal infusions were started and consisted of 1) 
water; 2) starch (2 kg/d); 3) casein (0.86 kg/d); or 4) 
the combination of starch plus casein (2 kg/d of starch 
+ 0.86 kg/d of casein). Starch and casein were pur-
chased from National Starch and Chemistry Company 
(Bridgewater, NJ) and International Ingredient Cor-
poration (St. Louis, MO), respectively. Infusates were 
delivered in a total of 95 kg of water/d using peristaltic 
pumps (Harvard Apparatus Co. Inc., Millis, MA) set to 
deliver approximately 0.066 kg/min. Suspensions were 
maintained by continuous stirring.
Milking and Milk Samples
Animals were milked at 0800 and 2000 h daily from 
d 1 to 13 of each period. On d 14, cows were milked 
every hour from 0800 to 1600 h (the last 8 h of the 
infusion) and samples were collected. An aliquot of 
milk was submitted for analyses of fat, true protein, 
lactose, total solids, and somatic cells (AOAC, 1997) 
by infrared analyses (DHIA, Blacksburg, VA; Foss 4000 
Combi North America, Eden Prairie, MN). The MUN 
analyses were conducted using the Berthelot proce-
dure (ChemSpec 150 Analyzer; Bentley Instruments, 
Chaska, MN).
Surgeries and Catheter Maintenance
Two weeks before the onset of the study, a perma-
nent indwelling catheter was introduced approximately 
40 cm into the intercostal artery (for catheter details, 
see Mackle et al., 2000). During the study, 4 catheters 
failed and replacement catheters were inserted into the 
contralateral intercostal artery. On d 11, one indwelling 
catheter was inserted into the jugular vein and another 
catheter was inserted into the subcutaneous abdominal 
vein. The venous catheters were removed on d 14 of 
each period after completion of sampling. Arterial cath-
eters were flushed weekly with a 0.9% NaCl solution 
containing 400 IU of heparin (Baxter, Deerfield, IL). A 
second solution containing 20 IU of heparin was used to 
flush the catheters during the sampling sessions.
Blood Collection, Hormone,  
and Metabolite Concentrations
During the last 8 h of each infusion period, arterial 
and venous samples (~7 mL) were collected simulta-
neously every 20 min into heparinized syringes. They 
were subsequently transferred to heparinized tubes 
to be analyzed for glucose concentrations. Blood was 
harvested while cows were standing to ensure repre-
sentative sampling from the abdominal vein. Plasma 
was prepared by centrifugation (2,000 × g for 10 min), 
pooled by hour within cow, and stored at −20°C until 
analysis. Samples were subsequently analyzed for glu-
cose, insulin, IGF-I, and AA. Glucose concentrations 
were determined using an enzymatic method (accord-
ing to manufacturer procedures; Beckman Coulter Inc., 
Fullerton, CA). The intraassay CV was <3%. Insulin 
and IGF-I were determined by double-antibody RIA as 
described by Daniels et al. (2008). For the IGF-I assay, 
acid-ethanol extraction of binding proteins preceded 
the RIA. Intra- and interassay CV were 2.1 and 1.3%, 
respectively, for IGF-I, and 3.2 and 2.4%, respectively, 
for the insulin concentrations. Equal hourly blood ali-
quots were pooled by period and cow and analyzed for 
hematocrit. Equal hourly plasma aliquots were pooled 
by period and cow and analyzed for NEFA, triglyceride 
(TG), and IGF-I-binding proteins (IGFBP)-3, 4, and 
5. Concentrations of NEFA (Wako Chemicals, Rich-
mond, VA) and TG were determined using an enzy-
matic method (Beckman Coulter Inc.). The intraassay 
CV was less than 1% for each metabolite. Ligand blot-
ting was used to determine the relative abundance of 
IGFBP-3, 4, and 5 as described by Daniels et al. (2008). 
Gels were electrophoresed at the same time to minimize 
gel-to-gel variation. Proteins were electrotransferred to 
a nitrocellulose membrane incubated with 125I-IGF-I 
(1 × 106 cpm/mL) overnight, washed in Tris-buffered 
saline, and visualized by autoradiography (Amersham, 
Piscataway, NJ) for 24 h at −80°C. The relative abun-
dance of binding proteins was determined by scanning 
densitometry (Un-Scan It v6.1, Orem, UT). Free AA 
were determined by isotope dilution using a GC-MS 
(Focus-PolarisQ GC-MS, Thermo Electron Corp., 
Waltham, MA) according to the methods of El-Kadi et 
al. (2004) and Calder et al. (1999).
Mammary Biopsy
Mammary glands were prepared for biopsy and tis-
sue was collected at the end of the infusion periods 
from right and left rear MG as described by Harvatine 
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and Bauman (2006). Briefly, mammary biopsies were 
collected using a biopsy tool (Magnum Core Biopsy 
System, Bard, Covington, GA) fitted with a 12-gauge 
needle. One portion of the collected tissue (~0.1 g) 
was immediately snap-frozen in liquid N and stored at 
−80°C for later analysis of AA. A second portion was 
processed for Western blot analysis. Clots resulting from 
the biopsies were removed by hand over the next 2 to 
3 d. All biopsied quarters were cultured for pathogens 
subsequent to the biopsy and found to remain clear of 
infection.
Cell Signaling Analysis
Tissue samples from mammary biopsies (0.1 g) were 
processed for Western immunoblotting analysis as de-
scribed previously (Escobar et al., 2006). Briefly, tissue 
was mixed 1:7 (wt/vol) with homogenization buffer 
containing a mix of protease and phosphatase inhibitors 
(Sigma Chemical Co., St. Louis, MO), homogenized for 
40 s (Power Gen 1000, Fisher Scientific, Waltham, MA), 
and centrifuged at 10,000 × g for 10 min at 4°C. The 
supernatant was diluted in Laemmli SDS sample buf-
fer, boiled for 5 min, and stored at −80°C until protein 
immunoblot analyses. Proteins were electrophoretically 
separated in polyacrylamide gels and transferred to a 
polyvinylidene fluoride membrane (Bio-Rad, Hercules, 
CA), blocked with 5% nonfat dry milk in a Tris-base 
Tween buffer (10 mM Tris base, 150 mM NaCl, and 1% 
Tween 20), and probed with various antibodies recog-
nizing the signaling proteins of interest including en-
dothelial nitric oxide synthase (eNOS), protein kinase 
B (AKT), ribosomal protein S6 (rpS6), and mTOR as 
described previously (Escobar et al., 2006). All antibod-
ies were procured from Cell Signaling Technology (Dan-
vers, MA) and included anti-phospho-eNOS (Ser1177), 
anti-α tubulin, anti-phospho-AKT (Ser473), anti-total 
AKT, anti-phospho-mTOR (Ser2448), anti-total mTOR, 
anti-phospho-rpS6 (Ser235/236 and Ser240/244), and anti-
total rpS6. Membranes for eNOS determination were 
probed for anti-phospho-eNOS, and then stripped and 
reprobed to determine α tubulin. The antibody recog-
nizing total eNOS did not cross-react with the bovine 
molecule, thus necessitating the use of the α tubulin an-
tibody as a loading control. The remaining membranes 
were probed initially for the phosphorylated initiation 
factors, and then stripped and reprobed to determine 
the abundance of the total form of these initiation fac-
tors. Blots were developed using an enhanced chemi-
luminescence kit (ECL Plus, Amersham, Piscataway, 
NJ) and visualized using enhanced chemiluminescence 
film and a medical film processor (SRX 101A Konica 
Minolta, Wayne, NJ). The films were scanned and 
bands quantified by densitometry as described above. 
Band intensities were used to calculate the ratio of 
phosphorylated to total protein (or tubulin in the case 
of eNOS), which is indicative of the phosphorylation 
state of that particular protein.
Measurements and Calculations
Mammary plasma flow (MPF, L/h) was calculated 
according to the Fick principle using plasma and milk 
Met, Thr, Lys, and Phe plus Tyr flux with an allow-
ance for 3.5% contribution from blood-derived proteins 
(Thivierge et al., 2002) and assuming quantitative con-
version to milk protein:
MPF = (AAm × 0.965)/AVAA × (1 – hematocrit),
where AAm represented each milk AA (μmol/h) and 
AVAA represented the arterio-venous (AV) concentra-
tion differences (μmol/L) for each essential AA (EAA). 
Milk AA composition was calculated from Hanigan et 
al. (2004). The independent estimates of flow provided 
by each AA were averaged to derive a final flow for each 
time point and animal.
Clearance rates (k, L/h) of the MG were calculated 
from the model of Hanigan et al. (1998b) as applied in 
Bequette et al. (2000):
ki = MPF × AV/[Vi],
where [Vi] represented venous plasma concentrations of 
the ith AA (μmol/L). The advantage of this form over 
the use of extraction efficiency is that the clearance 
rate accommodates changes in plasma flow. Clearance 
is the net uptake of the metabolite relative to its venous 
concentrations. Net uptake (μmol/h) of metabolites 
across the MG was calculated as
Uptakei = MPF × AVi.
Statistical Analysis
The main effects of starch and casein and the in-
teraction between starch and casein were tested as 
summarized in Table 2. Statistical computations were 
performed using the Proc Mixed procedure of SAS 
(2001, version 3.01; SAS Institute Inc., Cary, NC). 
Cow was defined as a random effect, and period and 
treatment were defined as fixed effects for the analyses 
of hormones, NEFA, TG, and Western blotting. The 
same model was used for analyses of milk yield, milk 
composition, and milk component yields, plasma AA 
and glucose, plasma flow, and mammary calculations 
with added consideration for the effects of repeated 
measures in time. The autoregressive covariance struc-
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ture was used based on goodness of fit as indicated by 
Akaike’s information criterion, Bayesian information 
criterion, and Akaike’s information criterion corrected. 
Unless otherwise stated, significance was declared at P 
≤ 0.05.
RESULTS
Intake, Milk Production, and Milk Components
The chemical composition of dietary ingredients is 
presented in Table 3, and animal performance data are 
presented in Table 4. Intake of TMR (not considering 
infusates) was greater in animals infused with starch 
relative to cows infused with casein (P = 0.01), primar-
ily because of a greater intake for cows infused only 
with starch (casein × starch interaction, P = 0.01).
Milk production and composition are presented in 
Table 4. Infusions of starch increased milk yield (P = 
0.02); however, there were no evident effects of casein 
infusion on milk yield, and there was no interaction 
between casein and starch. However, there was an inter-
action between casein and starch for milk protein yield 
with an increase in response to casein in the presence of 
starch (P = 0.02). Relative to starch, infusions of casein 
increased milk protein percentage (P = 0.03); however, 
there was a negative response to casein in the presence 
of starch that reduced milk protein percentage (casein × 
starch interaction, P = 0.04). Milk urea N was reduced 
by infusion of starch (P = 0.01) and increased by the 
infusion of casein (P = 0.01). Lactose yield was greater 
in cows treated with starch (P = 0.01). Neither starch 
nor casein had an effect on milk fat yield, but there was 
an interaction, with a positive response to casein in the 
presence of starch (P = 0.03). There was an increase in 
SNF yield in cows infused with starch (P = 0.03) and a 
casein × starch interaction (P = 0.03) with a negative 
response to casein in the absent of starch and a positive 
response in the presence of starch.
Insulin, IGF-I, and IGFBP
Insulin, IGF-I, and IGFBP data are presented in 
Table 5. Cows that received starch infusions had in-
creased insulin and IGF-I concentrations (P = 0.01). 
There was a trend for an insulin interaction between 
casein and starch, with a negative response to casein in 
the presence of starch (P = 0.08). There was an interac-
tion between casein and starch for relative abundance 
of IGFBP-4 and 5, with a negative response to casein in 
the presence of starch (P = 0.05). There was a trend for 
an interaction of casein and starch on IGFBP-3 relative 
abundance with a negative response to casein in the 
presence of starch (P = 0.06).
Metabolite Kinetics and Plasma Flow
Arterial plasma concentrations of energy-yielding 
metabolites, AV differences, clearance rates, and net 
uptake are presented in Table 6. Plasma flow was in-
creased in cows infused with starch (P = 0.01) as were 
arterial plasma concentrations of glucose (P = 0.01), 
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Table 2. Definition of the effects for the statistical model 
Effect Type df ddfm1
Starch (S)2 Fixed 1 8
Casein (CN)2 Fixed 1 8
CN × S Fixed 1 8
Period2 Fixed 3 8
Cow2 Random 5  
Error Random 8  
  19  
Hour (H)2 Fixed 8 128
S × H Fixed 8 128
CN × H Fixed 8 128
CN × S × H Fixed 8 128
Residual Random 128  
Total  179  
1ddfm = denominator degrees of freedom for F-test.
2The effects of starch, casein, period, cow, and hour.
Table 3. Chemical composition of the feed ingredients of the basal diet (% DM basis) 
Item Haylage Corn silage Forage mix Concentrate
DM 55.7 27.8 30.4 91.5
NDF 43.2 43.3 43.9 31.2
ADF 34.2 26.1 26.3 21.0
CP 21.6 7.2 9.7 23.5
Fat 3.3 4.1 3.8 2.9
Lignin 7.1 2.1 2.6 1.9
Starch 0.5 30.6 23.6 17.8
Sugar 2.6 1.0 2.2 5.7
Minerals     
 Ash 11.1 3.1 4.8 6.4
 Calcium 1.0 0.2 0.6 0.8
 Phosphorous 0.4 0.2 0.3 0.4
 Magnesium 0.3 0.2 0.3 0.3
but there was a casein × starch interaction for glucose, 
with the starch response greater in the absence of casein 
(P = 0.01). Arterio-venous concentration differences of 
glucose increased in response to casein infusion in the 
absence of starch but decreased in response to casein in 
the presence of starch (P = 0.02). Net uptake of glucose 
was increased by infusion of starch (P = 0.01). These 
changes in uptake were likely caused, at least partially, 
by changes in mammary glucose clearance rate, which 
increased in response to casein in the absence of starch, 
but declined in response to casein in the presence of 
starch (P = 0.01).
Arterial NEFA concentrations were lower in cows 
infused with casein (P = 0.05) but were unaffected by 
starch. Net uptake of NEFA by MG was reduced in 
cows infused with starch (P = 0.01) but increased in 
cows infused with casein (trend, P = 0.07).
Arterial concentrations of AA are presented in Table 
7. Casein infusions increased plasma concentrations 
of all EAA (P = 0.02) except Phe. Casein infusions 
increased plasma concentrations of Cys, Pro, Ser, and 
Tyr (P = 0.02) but reduced arterial concentrations 
of Gln (P = 0.01). Starch infusions reduced arterial 
concentrations of Ile, His, Leu, Lys, Phe, and Val (P 
= 0.05) and tended to reduce Met concentrations (P 
= 0.07). Infusions of starch reduced arterial concentra-
tions of the nonessential AA Asp, Gln, Glu, and Pro 
(P = 0.01) and tended to reduce Trp and Ala plasma 
concentrations (P = 0.08). However, starch infusions 
increased Gly concentrations (P = 0.01). There was 
a casein × starch interaction for Leu and Trp with a 
positive response to casein in the absence of starch (P 
= 0.01). There was also a casein × starch interaction 
for arterial concentrations of Ala, Cys, and Gln (P = 
0.01) with reduced Cys concentrations and increased 
Ala and Gln concentrations in response to casein in the 
presence of starch.
Arterio-venous concentration differences of AA are 
presented in Table 8. Infusions of casein increased AV 
for Ile, Leu, Lys, Thr, Phe, Glu, Gln, Gly, Pro, and 
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Table 4. Effect of 2 levels of starch (S) and casein (CN) infused in the abomasum of intake-restricted lactating dairy cows on total DMI, milk 
yield, and milk composition 
Item
Experimental treatment1
SEM
P-value
Water CN S S+CN S CN CN × S
DMI + infusate, 2 kg/d 13.0 14.7 17.9 16.9 0.8 0.01 0.4 0.01
DMI,3 kg/d 13.0 13.6 15.6 13.6 0.8 0.01 0.2 0.01
Milk yield, kg/h 0.98 0.83 1.09 1.20 0.10 0.02 0.8 0.2
Protein yield, g/h 31.4 25.0 30.2 37.5 4.2 0.05 0.8 0.02
Lactose yield, g/h 45.5 35.3 44.6 56.5 7.0 0.01 0.8 0.1
Fat yield, g/h 48.0 34.9 42.6 50.0 4.7 0.3 0.4 0.03
SNF yield, g/h 85.0 68.7 84.0 104.0 12.7 0.03 0.8 0.03
MUN, mg/dL 12.0 14.7 9.2 13.1 0.5 0.01 0.01 0.2
Protein, % 3.05 3.29 3.15 3.18 0.11 0.9 0.03 0.04
Lactose, % 4.35 4.41 4.59 4.62 0.12 0.01 0.3 0.7
Fat, % 4.68 4.40 4.25 3.73 0.30 0.05 0.1 0.6
SNF, % 8.32 8.68 8.66 8.68 0.12 0.01 0.01 0.01
1Treatments: 1) water (control); 2) casein (0.86 kg/d); 3) starch (2 kg/d); and 4) the combination of starch plus casein (2 kg/d of starch + 0.86 
kg/d of casein).
2TMR intake including infusate.
3Voluntary TMR intake without infusate.
Table 5. Effect of 2 levels of starch (S) and casein (CN) infused in the abomasum of intake-restricted lactating dairy cows on the arterial 
concentration of insulin, IGF-I, and IGF-I binding proteins (IGF-BP) 
Item
Experimental treatment1
SEM
P-value
Water CN S S+CN S CN CN × S
Hormone         
 Insulin, ng/mL 0.78 0.85 1.29 1.0 0.18 0.01 0.8 0.08
 IGF-I, ng/mL 352 376 399 405 51 0.01 0.3 0.5
IGF binding proteins2         
 IGF-BP3 326 350 356 261 30 0.3 0.2 0.06
 IGF-BP4 247 349 277 246 33 0.2 0.3 0.05
 IGF-BP5 171 170 183 127 15 0.2 0.04 0.05
1Treatments: 1) water (control); 2) casein (0.86 kg/d); 3) starch (2 kg/d); and 4) the combination of starch plus casein (2 kg/d of starch + 0.86 
kg/d of casein).
2Arbitrary density units.
Ser (P = 0.04), but reduced AV for Ala and Cys (P = 
0.04). Infusions of starch increased AV for Ala, Glu, 
and Cys (P = 0.05). There was a reduction in AV for 
Phe in cows infused with starch (P = 0.01). There was 
a trend to reduce the AV of Leu by starch infusion (P 
= 0.07). Arterio-venous differences of Met, His, Thr, 
and Gln were affected by the interaction between casein 
and starch, with an increase in response to casein in the 
absence of starch and a reduction in response to casein 
in the presence of starch (P = 0.03). There was a trend 
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Table 6. Effect of 2 levels of starch (S) and casein (CN) infused in the abomasum of intake-restricted lactating dairy cows on plasma flow, 
arterial concentration, arterio-venous (AV) difference, net uptake, and clearance rates of energy-yielding metabolites 
Item
Experimental treatment1
SEM
P-value
Water CN S S+CN S CN CN × S
Plasma flow, L/h 419 324 547 505 75 0.01 0.3 0.6
Arterial concentrations         
 Glucose, mmol/L 4.1 4.3 4.6 4.3 0.16 0.01 0.5 0.01
 NEFA, mEq/L 0.24 0.17 0.14 0.16 0.03 0.4 0.05 0.1
 Triglycerides, mg/dL 9.0 9.1 8.8 8.4 0.7 0.6 0.9 0.8
AV difference         
 Glucose, mmol/L 0.49 0.78 0.63 0.51 0.11 0.4 0.3 0.02
 NEFA, mEq/L 0.001 0.002 −0.031 −0.009 0.007 0.01 0.1 0.1
 Triglycerides, mg/dL 3.7 3.5 3.0 3.1 1.1 0.5 0.9 0.8
Net uptake2         
 Glucose, mmol/h 201 252 409 330 88 0.01 0.8 0.2
 NEFA, mEq/h −0.24 4.37 −20.7 −5.5 5.0 0.01 0.07 0.3
 Triglycerides, mg/h 1,693 1,642 1,618 1,510 565 0.8 0.8 0.9
Clearance rate3         
 Glucose, L/h 70 135 122 82 20 0.9 0.5 0.01
1Treatments: 1) water (control); 2) casein (0.86 kg/d); 3) starch (2 kg/d); and 4) the combination of starch plus casein (2 kg/d of starch + 0.86 
kg/d of casein).
2Net uptake of metabolites across the mammary glands was calculated as MPF × AVmet, where MPF is the mammary plasma flow (L/h) and 
AVmet represents metabolite differences between arterial and venous concentrations.
3ki = MPF × AVmet/[Vi] (from Hanigan et al., 1998b), where ki is the clearance rate and [Vi] represents venous plasma concentrations of glucose 
(mmol/L).
Table 7. Effect of 2 levels of starch (S) and casein (CN) infused in the abomasum of intake-restricted lactating dairy cows on arterial 
concentrations (μM) of AA 
Item
Experimental treatment1
SEM
P-value
Water CN S S+CN S CN CN × S
Essential AA     
 Arg 76 98 72 99 7 0.8 0.01 0.6
 Ile 82 131 64 109 8 0.01 0.01 0.6
 His 30 39 27 36 3 0.05 0.01 0.9
 Leu 116 205 85 150 6 0.01 0.01 0.01
 Lys 63 96 52 83 5 0.01 0.01 0.7
 Met 22 27 19 27 2 0.07 0.01 0.2
 Phe 89 94 64 77 13 0.04 0.2 0.5
 Thr 59 85 57 82 6 0.7 0.01 0.6
 Trp 95 99 99 100 1 0.08 0.02 0.01
 Val 190 350 140 272 18 0.01 0.01 0.2
Total essential AA 753 1,147 622 962 80 0.01 0.01 0.5
Branched-chain AA 375 683 294 533 26 0.01 0.01 0.1
Nonessential AA         
 Ala 160 143 148 170 12 0.07 0.5 0.01
 Asp 7 7 5 6 1 0.01 0.1 0.07
 Cys 16 17 19 15 1 0.5 0.02 0.01
 Gln 92 33 32 71 11 0.01 0.01 0.01
 Glu 30 32 25 28 2 0.01 0.1 0.8
 Gly 191 192 222 216 10 0.01 0.7 0.6
 Pro 57 136 42 122 8 0.01 0.01 0.9
 Ser 64 84 62 83 4 0.6 0.01 0.8
 Tyr 37 58 32 57 3 0.1 0.01 0.3
Total nonessential AA 693 682 639 761 25 0.5 0.02 0.1
1Treatments: 1) water (control); 2) casein (0.86 kg/d); 3) starch (2 kg/d); and 4) the combination of starch plus casein (2 kg/d of starch + 0.86 
kg/d of casein).
to increase AV of Lys and Gly in response to casein 
with or without starch (P = 0.09). Arterio-venous dif-
ferences of Cys did not change in response to casein in 
the absence of starch but were reduced in the presence 
of starch (P = 0.03).
Clearance rates of plasma AA from the MG are 
presented in Table 9. Clearance rates of Arg, Ile, Leu, 
Lys, Phe, Trp, Ala, Glu, and Tyr were increased dur-
ing starch infusions (P = 0.03). There was a trend to 
increase the clearance rate of Asp by starch infusion (P 
= 0.07). The clearance rates of Ile, Ala, and Cys were 
reduced, whereas that of Gln was increased by the infu-
sion of casein (P = 0.05). Clearance rates of His, Met, 
Phe, Thr, Ala, and Tyr were affected by the casein × 
starch interaction with a positive response to casein 
in the absence of starch and a negative response in 
the presence of starch (P = 0.05). There was a similar 
trend for a casein × starch interaction in the clearance 
rate of Trp (P = 0.08). The net uptake of AA by the 
mammary gland is presented in Table 10. Infusions of 
starch increased the net uptake of Arg, Ile, Lys, Phe, 
Trp, Ala, Asp, Cys, Gln, Glu, Ser, and Tyr (P = 0.05). 
There was a trend for starch infusions to increase Val 
uptake (P = 0.08). Casein infusions reduced net uptake 
of Ala and Cys (P = 0.05), whereas casein tended to 
increase uptake of His and Gln (P = 0.09). Casein infu-
sions increased net uptake of Pro, Ser, and Tyr (P = 
0.04). Net uptake of His, Met, Thr, and Ala were af-
fected by the casein and starch interaction with greater 
uptake in response to casein in the absence of starch 
and a reduction in the presence of starch (P = 0.05). 
Net uptake of Trp showed a trend for the casein × 
starch interaction, with greater uptake in response to 
casein in the absence of starch and a reduction in the 
presence of starch (P = 0.08).
Cell Signaling
The ratio of phosphorylated to total abundance of 
mTOR, AKT, and rpS6 in the MG are presented in 
Figure 1. Infusions of starch increased the phospho-
rylation ratio of rpS6 (P = 0.03). However, infusion 
of casein failed to increase the phosphorylation ratio 
of mTOR. There was an interaction between starch 
and casein for phosphorylation state of mTOR with 
increased phosphorylation in response to casein when 
starch was present and a decline in response to casein 
in the absence of starch (P = 0.05). There was a trend 
for the interaction of casein and starch on the phospho-
rylation ratio for AKT (P = 0.14) with an increase in 
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Table 8. Effect of 2 levels of starch (S) and casein (CN) infused in the abomasum of intake-restricted lactating dairy cows on arterio-venous 
difference (μM) of AA1 
Item
Experimental treatment2
SEM
P-value
Water CN S S+CN S CN CN × S
Essential AA     
 Arg 15 24 22 28 9 0.4 0.3 0.1
 Ile 24 32 21 35 3 0.8 0.01 0.3
 His 1 6 5 3 2 0.3 0.1 0.03
 Leu 36 56 30 48 4 0.07 0.01 0.8
 Lys 25 35 25 36 3 0.9 0.01 0.09
 Met 6 9 10 8 1 0.1 0.05 0.01
 Phe 38 84 21 53 37 0.01 0.01 0.2
 Thr 10 23 18 17 3 0.1 0.01 0.01
 Trp 12 12 13 13 2 0.5 0.9 0.9
 Val 30 25 23 26 7 0.6 0.8 0.5
Total essential AA 121 242 174 169 35 0.6 0.02 0.01
Branched-chain AA 80 128 83 111 15 0.6 0.01 0.41
Nonessential AA         
 Ala 12 1 23 2 7 0.05 0.01 0.1
 Asp 2 3 2 2 1 0.6 0.7 0.5
 Cys 1 1 8 3 2 0.01 0.04 0.03
 Gln 3 3 −3 12 3 0.5 0.01 0.01
 Glu 14 19 19 26 2 0.01 0.01 0.6
 Gly −14 −13 −25 3 7 0.7 0.04 0.06
 Pro 2 16 4 10 3 0.6 0.01 0.1
 Ser 8 18 9 15 4 0.5 0.01 0.5
 Tyr 9 9 11 11 2 0.4 0.94 0.9
Total nonessential AA 1 37 36 53 15 0.06 0.05 0.4
1Positive values indicate plasma AA removal; negative values indicate AA released from the mammary glands. 
2Treatments: 1) water (control); 2) casein (0.86 kg/d); 3) starch (2 kg/d); and 4) the combination of starch plus casein (2 kg/d of starch + 0.86 
kg/d of casein).
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Table 9. Effect of 2 levels of starch (S) and casein (CN) infused in the abomasum of intake-restricted lactating dairy cows on clearance rates1 
(L/h) of AA by the mammary glands 
Item
Experimental treatment2
SEM
P-value
Water CN S S+CN S CN CN × S
Essential AA     
 Arg 10 112 241 228 67 0.01 0.4 0.3
 Ile 179 99 265 193 43 0.03 0.05 0.8
 His −34 125 127 36 41 0.2 0.3 0.01
 Leu 153 153 337 225 50 0.01 0.7 0.9
 Lys 220 270 469 359 77 0.01 0.6 0.1
 Met 178 304 350 159 115 0.8 0.6 0.02
 Phe 33 128 611 266 124 0.01 0.2 0.05
 Thr 87 265 199 117 35 0.6 0.2 0.01
 Trp −2.1 0.5 2.2 1.1 1.5 0.02 0.6 0.08
 Val 76 38 75 77 19 0.2 0.9 0.2
Nonessential AA         
 Ala 2.0 22 86 7.8 18 0.01 0.04 0.01
 Asp 151 247 518 376 118 0.07 0.8 0.3
 Cys 14 −83 69 −68 40 0.3 0.01 0.6
 Gln −94 22 −120 −13 58 0.1 0.01 0.8
 Glu 66 713 1,108 1,227 393 0.02 0.2 0.4
 Gly −44 −28 −31 −10 31 0.4 0.3 0.9
 Pro 45 60 52 34 18 0.6 0.9 0.3
 Ser 105 98 85 130 41 0.8 0.5 0.4
 Tyr 28 178 293 180 56 0.02 0.7 0.03
1ki = MPF × AVmet/[Vi] (from Hanigan et al., 1998b), where ki is the clearance rate, [Vi] represents venous plasma concentrations of the ith AA 
(μmol/L), and MPF is the mammary plasma flow (L/h). Positive values indicate uptake and negative values indicate output by the mammary 
glands.
2Treatments: 1) water (control); 2) casein (0.86 kg/d); 3) starch (2 kg/d); and 4) the combination of starch plus casein (2 kg/d of starch + 0.86 
kg/d of casein).
Table 10. Effect of 2 levels of starch (S) and casein (CN) infused in the abomasum of intake-restricted lactating dairy cows on AA net uptake 
(M/h) in the mammary glands1 
Item
Experimental treatment2
SEM
P-value
Water CN S S+CN S CN CN × S
Essential AA     
 Arg 3.4 4.4 10 14 3.4 0.01 0.4 0.7
 Ile 8.9 8.5 11 18 2.5 0.01 0.1 0.1
 His 0.3 3.3 1.3 0.3 1.0 0.5 0.09 0.01
 Leu 15 16 16 22 5.0 0.3 0.4 0.5
 Lys 9.3 11 13 18 2.6 0.03 0.1 0.6
 Met 1.6 3.7 3.4 1.3 1.0 0.6 0.9 0.01
 Phe 3.1 4.6 20 15 5.7 0.04 0.4 0.3
 Thr 3.3 11 10 5.6 2.5 0.5 0.6 0.01
 Trp 0.2 1.5 2.2 1.1 1.0 0.02 0.6 0.08
 Val 6.7 10 13 19 4.3 0.08 0.2 0.7
Nonessential AA         
 Ala 0.8 1.7 14 1.5 3.5 0.02 0.01 0.01
 Asp 0.7 0.7 1.3 1.0 0.4 0.05 0.7 0.9
 Cys 0.8 0.1 2.4 0.5 0.7 0.03 0.01 0.9
 Gln −1.1 1.3 −3.6 0.2 1.3 0.01 0.06 0.7
 Glu 7.5 8.5 10 14 3.2 0.05 0.2 0.4
 Gly −5.1 −1.7 −8.4 3.9 4.0 0.4 0.2 0.9
 Pro 0.5 8.4 2.3 6.6 1.4 0.9 0.01 0.3
 Ser 0.1 5.6 5.2 7.7 2.0 0.04 0.04 0.5
 Tyr 0.1 5.1 6.4 7.3 1.5 0.01 0.05 0.2
1Net uptake of AA across the mammary glands was calculated as MPF × AVAA, where AVAA represents AA differences between arterial and ve-
nous concentrations and MPF is the mammary plasma flow (L/h). Positive values indicate net removal and negative values indicate net release 
from the mammary glands.
2Treatments: 1) water (control); 2) casein (0.86 kg/d); 3) starch (2 kg/d); and 4) the combination of starch plus casein (2 kg/d of starch + 0.86 
kg/d of casein).
response to casein in the presence of starch. Infusions 
of starch tended (P = 0.06) to increase the ratio of 
phosphorylated eNOS to tubulin (Figure 2).
DISCUSSION
A critical limitation to current MP and AA require-
ment systems is the assumption that a given level of 
milk protein output requires a fixed proportion of me-
tabolizable AA, despite observations of large variations 
in postabsorptive conversion efficiencies (Hanigan et 
al., 1998a; Cant et al., 2002; Hanigan, 2005). Variable 
efficiency is consistent with the biological mechanisms 
regulating N metabolism. Approximately 50% of car-
diac output, and therefore systemic AA, flows through 
the splanchnic tissues (Davis et al., 1988; Huntington 
et al., 1990), and thus AA not removed from blood 
for milk protein synthesis on a given transit through 
the udder are subsequently subject to clearance by the 
splanchnic tissues (Hanigan, 2005). If mammary uptake 
of AA is stimulated, recycling and use by other tissues 
will decline if AA supply is fixed; this is consistent with 
the model of postabsorptive AA metabolism presented 
by Hanigan et al. (1998a).
The observed increase in milk protein output (Table 
4) when cows were infused with starch probably resulted 
from increased insulin and IGF-I concentrations (Table 
5). It has been previously demonstrated that hyper-
insulinemia stimulates milk protein synthesis whether 
occurring in response to infused insulin (McGuire et al., 
1995; Bequette et al., 2001) or when caused by elevated 
glucose concentrations (Rulquin et al., 2004). Increased 
insulin and IGF-I concentrations are consistent with in-
creased rpS6 phosphorylation (Davis et al., 2001; Proud, 
2007). Ribosomal protein S6 is thought to stimulate ri-
bosomal biogenesis through preferential stimulation of 
initiation rates of mRNA characterized by a 5′ tract of 
oligopyrimidines, although this role has been questioned 
(Proud, 2007). Its phosphorylation has been reported to 
occur via the AKT (O’Connor et al., 2003) and mTOR 
pathway (Proud, 2007; Figure 3). However, in the cur-
rent study, phosphorylation of mTOR increased only 
when both casein and starch were infused, and there 
was no evidence for increased AKT phosphorylation in 
response to the elevated insulin and IGF-I concentra-
tions during starch infusions. Phosphorylation of rpS6 
and mTOR was found to be highly correlated using an 
in vitro bovine mammary cell model (Appuhamy et al., 
2009). It is possible that an IGF-I–induced rpS6 phos-
phorylation occurs via the mitogen-activated protein 
kinase or the AMP kinase pathways (see Proud, 2007), 
which acts independently of AKT. This, however, does 
not explain the lack of a phosphorylation response in 
mTOR when animals were infused with starch in the 
absence of casein infusions. Phosphorylation of rpS6 
can also occur via RSK (ribosomal S6 kinase; Roux et 
al., 2007), which may explain the difference found be-
tween mTOR and rpS6 phosphorylation. Additionally, 
the downstream target of mTOR, p70S6K1, has been 
reported to inhibit insulin actions via phosphorylation 
of IRS-1 (insulin receptor substrate 1; Tremblay et al., 
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Figure 1. Effect of 2 levels of starch (S) and casein (CN) infused in 
the abomasum of intake-restricted lactating dairy cows on protein ini-
tiation factor activities in the mammary glands. Bars represent LSM 
(±SE) of phosphorylated to total relative abundance ratios of arbi-
trary density units. There was an interaction of CN and S on mamma-
lian target of rapamycin (mTOR; P = 0.05), with the response to CN 
in the absence of S negative and the response to CN in the presence of 
S positive. Cows infused with S increased the ratio of phosphorylated 
to total relative abundance of ribosomal protein S6 (rpS6; P = 0.03). 
Akt = protein kinase B.
Figure 2. Effect of 2 levels of starch (S) and casein (CN) infused 
in the abomasum of intake-restricted lactating dairy cows on activity 
of endothelial nitric oxide synthase (eNOS) to α tubulin ratio in the 
mammary glands. Bars represent LSM (±SE) of phosphorylated eNOS 
to α tubulin relative ratios of arbitrary density units. Starch tended 
to increase the ratio of phosphorylated eNOS to α tubulin relative 
abundance (P = 0.06). 
2007), which may explain the lack of both an AKT and 
an mTOR response. Finally, recent work has identified 
an alternative mTOR phosphorylation site that pur-
portedly responds to AKT and AA and controls mTOR 
activity (Acosta-Jaquez et al., 2009). It is possible that 
the phosphorylation of the alternative site is not highly 
correlated to phosphorylation of Ser2448, resulting in the 
disparate signaling pattern. However, we have previ-
ously observed independent effects of insulin and AA 
on Ser2448 in bovine mammary cells in vitro (Bell et 
al., 2009) and have found phosphorylation of Ser2448 to 
be highly correlated with rates of protein synthesis in 
mammary tissue slices from lactating cows (Appuhamy 
et al., 2009).
The lack of milk protein yield and mTOR phosphory-
lation responses to casein infusions are also surprising. 
Burgos et al. (2010) reported that AA availability in 
mammary epithelia increased protein synthesis by 50% 
and regulated signaling activity, which was enhanced 
by adding a combination of hydrocortisone, insulin, and 
prolactin to the medium. Escobar et al. (2006) reported 
that Leu activated the mTOR cascade and protein ac-
cretion in the muscle of growing piglets. The supply of 
AA is a key signal that activates mTOR signaling (Bol-
ster et al., 2004); however, in the experiment reported 
here, increasing the mammary supply of AA did not 
stimulate the mTOR cascade or protein synthesis. It 
may be that the change in AA concentrations achieved 
with a 30% feed restriction and casein infusion for 36 h 
was not adequate to detect differences in mTOR activ-
ity and protein synthesis. Escobar et al. (2006) fasted 
their piglets overnight and infused with large doses of 
individual AA, which created 3-fold or greater changes 
in blood concentrations compared with responses of 
1-fold or less in the study reported herein. Burgos et 
al. (2010) increased AA availability 4 times the arterial 
concentrations determined in well-fed lactating cows 
reported by Mackle et al. (2000).
Essential AA required by mammary cells to support 
increased milk protein output during starch infusions 
were acquired through a combination of increased 
mammary clearance rates for certain AA (Table 9) and 
increased MPF (Table 6). The combination resulted in 
increased net uptake (Table 10) of AA despite reduced 
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Figure 3. A partial schematic representation of the signaling pathways thought to regulate protein synthesis and their purported interac-
tions based on the literature. TCA represents the tri-carboxylic acid cycle; → represent fluxes, – –> represents activation, and – –∣ represents 
inhibition. Color version available in the online PDF.
arterial concentrations (Table 6) during starch infu-
sions. Increased mammary clearance rates of AA are 
part of a local adaptive mechanism to support protein 
synthesis, wherein clearance rate is matched to cellular 
needs (Moore et al., 1977; Bequette et al., 2000; Raggio 
et al., 2006) and is predicted by the model of Hanigan 
et al. (2000).
The decline in arterial AA concentrations during 
starch infusions might be a result of a decrease in AA 
catabolism. The reduction of AA catabolism is evi-
denced by the observed decline in MUN concentrations 
(Table 4). These results are consistent with the initial 
hypothesis regarding the ability to regulate and reduce 
catabolic losses of AA and improve N efficiency. If other 
tissues are catabolizing AA by mass action (Hanigan et 
al., 1998a), any decline in AA concentrations in blood 
would lead to a decline in catabolic flux, an increase in 
postabsorptive and animal efficiencies, and reduced N 
loss to the environment.
The increase in MPF may have resulted from in-
creased insulin or IGF-I concentrations. Both have 
been reported to increase blood flow to the MG via 
AKT-dependent phosphorylation of eNOS resulting in 
greater nitric oxide production (Lacasse et al., 1996; 
Zeng and Quon, 1996; Iantorno et al., 2007). Although 
nitric oxide was not measured in the present study, 
there was a trend for increased phosphorylation and 
thus activation of eNOS (P = 0.06) in association with 
starch infusions. Such changes are consistent with the 
observed increases in MPF. However, as for mTOR, no 
changes in AKT phosphorylation were observed, and 
thus it is unclear what mechanism is responsible for the 
changes in eNOS phosphorylation.
Increased MPF is not consistent with the observations 
of Cant et al. (2002), in which increased local glucose 
supply (517 mM/h) resulted in increased arterial con-
centration (6.37 mM) but a decreased MPF. However, 
the increase in arterial glucose concentrations, in the 
study reported here, was much less than the increase 
elicited by the local glucose infusions used in the work 
of Cant et al. (2002), perhaps allowing the effects of 
insulin and IGF-I to predominate. Rigout et al. (2002) 
reported similar responses in MPF when varying glu-
cose supply, suggesting that the observations reported 
herein are valid.
The variable efficiency in N use resulting from the 
effect of energy supply and hormonal signals to the 
MG are not captured in the current NRC (2001) model, 
which contributes to the overall poor relative efficiency 
of dairy cows in converting dietary N to milk N (Be-
quette et al., 2003) when fed to NRC requirements.
CONCLUSIONS
Provision of starch during dietary restriction can 
stimulate the MG to synthesize more milk protein. 
Ribosomal protein S6 appears to mediate this effect, 
although phosphorylation of AKT and mTOR did not 
mirror that of rpS6. Endothelial nitric oxide synthase 
may be, at least in part, responsible for a greater MPF 
during starch infusions. The increase in milk protein 
output was supported by an increase in MG affinity for 
some EAA. These actions resulted in decreased arterial 
AA concentrations and reduced AA catabolism. Col-
lectively, this information can be used to improve the 
representation of protein synthesis regulation in meta-
bolic models and lead to more accurate predictions of 
AA requirements and improved N efficiency.
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